Cas:3084-40-0 Diethyl (hydroxymethyl)phosphonate manufacturer & supplier

Chemical Name:Diethyl (hydroxymethyl)phosphonate

CAS.NO:3084-40-0

Synonyms:(Hydroxymethyl)phosphonic acid diethyl ester Diethyl phosphonomethanol;diethyl hydroxymethylphosphonate;Diethyl (hydroxymethyl)phosphonate;Diethyl phosphonomethanol;Phosphonic acid, (hydroxymethyl)-, diethyl ester;Diethyl Phosphonometanol;EINECS 221-391-6;MFCD00014418;(Hydroxymethyl)phosphonic acid diethyl ester;Phosphonic acid, P-(hydroxymethyl)-, diethyl ester;4-Hydroxymethyldiethylphosphonate;AURORA KA-1421;diethyl hydroxy-methanephosphonate;Diethyl(hydroxymethyl)phosphonate

Molecular Formula:C₅H₁₃O₄P

Molecular Weight:168.128

HS Code:2931900090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:239.5±23.0 °C at 760 mmHg

Density:1.2±0.1 g/cm3

Index of Refraction:1.424

PSA:65.57000

Exact Mass:168.055145

LogP:-1.12

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:NONH for all modes of transpor

Packing Group:

Contact us for information like (Hydroxymethyl)phosphonic acid diethyl ester Diethyl phosphonomethanol chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Diethyl(hydroxymethyl)phosphonate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,EINECS 221-391-6 Use and application,(Hydroxymethyl)phosphonic acid diethyl ester technical grade,usp/ep/jp grade.

Related News: Rigosertib is a small molecule that inhibits cellular signaling in cancer cells by acting as a RAS mimetic. Current clinical development of rigosertib is centered upon the therapeutic management of MDS, a heterogeneous group of bone marrow disorders characterized by ineffective hematopoiesis that often develop into acute myeloid leukaemia (AML). Diethyl (hydroxymethyl)phosphonate manufacturer There is fierce competition for bulk APIs and overcapacity. However, some high-profit, small-scale drugs still have a good market space. Diethyl (hydroxymethyl)phosphonate supplier Rigosertib is a small molecule that inhibits cellular signaling in cancer cells by acting as a RAS mimetic. Current clinical development of rigosertib is centered upon the therapeutic management of MDS, a heterogeneous group of bone marrow disorders characterized by ineffective hematopoiesis that often develop into acute myeloid leukaemia (AML). Diethyl (hydroxymethyl)phosphonate vendor There is fierce competition for bulk APIs and overcapacity. However, some high-profit, small-scale drugs still have a good market space. Diethyl (hydroxymethyl)phosphonate factory Toxic forever chemicals have no place in personal care products,” Scott Faber, EWG’s senior vice president of government affairs. “PFAS have been linked to serious health problems, including cancer and harm to the reproductive and immune systems. EWG applauds Sen. Collins and Rep. Dingell for introducing the No PFAS in Cosmetics Act.